KaydedilenlerDerginizi ekleyin

Dergiler / Dicle Tıp Dergisi / 2026 / Cilt: 45 Sayı: 3

Stereotactic biopsy of the brain mass lesions: a tertiary hospital experience

Erkut Baha Bulduk0000-0002-8812-1290
Ayfer Aslan0000-0002-5413-7833
Özgür Öcal0000-0002-8985-2626
Ömer Hakan Emmez0000-0002-3290-179X
Gökhan Kurt0000-0002-2773-056X
Şükrü Aykol0000-0001-7896-1563
Sayfa
245–253
Yayın Tarihi
2018-09-05
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusions: Beside low risk of mortality and morbidity, the high rate of non-diagnostic results and low rate of diagnostic accuracy are the limitations of SB, which should be improved by careful skills to obtain more specimen, sophisticated software for planning, and intraoperative pathological examination for guaranteeing.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: Stereotactic biopsy (SB) is a guided technic performed for the lesions on eloquent brain areas.
📊
Temel Bulgular & Veri:The study took place in Department of Neurosurgery, Gazi University Faculty of Medicine between February 2004 and April 2014.
💡
Sonuç & Katkı:Conclusions: Beside low risk of mortality and morbidity, the high rate of non-diagnostic results and low rate of diagnostic accuracy are the limitations of SB, which should be improved by careful skills to obtain more specimen, sophisticated software for planning, and intraoperative pathological examination for guaranteeing.
🔬Tür:Araştırma Makalesi
📍Kapsam:2004 Verileri
⚙️Değişkenler:Stereotactic biopsy · Brain tumor

Özet

Objectives: Stereotactic biopsy (SB) is a guided technic performed for the lesions on eloquent brain areas. The aim of this study is revealing the diagnostic reliability and the risk ratio of SB. Methods: Data of patients performed SB due to various intracranial lesions was collected retrospectively. The study took place in Department of Neurosurgery, Gazi University Faculty of Medicine between February 2004 and April 2014. Data analysis performed in terms of age, gender, lesion location, histopathology, and outcomes of surgery. Results: Sixty percent of patients were male (146 patients) and forty percent of them was female (96 patients), between the ages of 11 and 84 years (mean age of 49 years) with a total number of 242. Mortality and morbidity rates were respectively 0.4% and 3.3%. The overall diagnostic yield was 81% (196 patients), while 19% (46 patients) had nonspecific results, which did cannot lead any further therapy. Among 36 patients of whom pathologies were confirmed with an excisional biopsy, the diagnostic accuracy was shown in 24 patients (67%). Conclusions: Beside low risk of mortality and morbidity, the high rate of non-diagnostic results and low rate of diagnostic accuracy are the limitations of SB, which should be improved by careful skills to obtain more specimen, sophisticated software for planning, and intraoperative pathological examination for guaranteeing.

🔖

Bu Makaleye Atıf Yap

Bulduk, E. B., Aslan, A., Öcal, Ö., Emmez, Ö. H., Kurt, G., Aykol, Ş. (2018). Stereotactic biopsy of the brain mass lesions: a tertiary hospital experience. Dicle Tıp Dergisi, Cilt: 45 Sayı: 3, 245–253. https://doi.org/10.5798/dicletip.457233

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (23)

  1. Horsley V, Clarke RH. The structure and functions of the cerebellum examined by a new method. Brain. 1908; 31: 45–124.
  2. Schulder M. Handbook of Stereotactic and Functional Neurosurgery, 1st edn. New Jersey Medical School, USA: CRC Press, 2003: 1-608
  3. Burger PC, Nelson JS. Stereotactic brain biopsies. Pathol Lab Med. 1997; 121: 477-80.
  4. Krieger MD, Chandrasoma PT, Zee CS, Apuzzo ML. Role of stereotactic biopsy in the diagnosis and management of brain tumors. Seminars in surgical oncology. John Wiley & Sons, Inc. 1998; 14: 1-11.
  5. Chandrasoma PT, Smith MM, Apuzzo ML. Stereotactic biopsy in the diagnosis of brain masses: comparison of results of biopsy and resected surgical specimen. Neurosurgery. 1989; 24: 160-5.
  6. Savas A. Beyin Biyopsisi – Stereotaksik Cerrahi Tekniği. Society of Turkish Neurosurgery, Basic Neurosurgery, 2nd edn: 1999, 2010.
  7. Kim JE, Kim DG, Paek SH, Jung HW. Stereotactic biopsy for intracranial lesions: reliability and its impact on the planning of treatment. Acta neurochirurgica. 2003; 145: 547-55.
  8. Fritsch MJ, Leber MJ, Gossett L, Lulu BA, Hamilton AJ. Stereotactic biopsy of intracranial brain lesions. High diagnostic yield without increased complications: 65 consecutive biopsies with early postoperative CT scans. Stereotact Funct Neurosurg. 1998; 71: 36-42.
  9. Greene GM, Hitchon PW, Schelper RL, Yuh W, Dyste GN. Diagnostic yield in CT-guided stereotactic biopsy of gliomas. J Neurosurg. 1989; 71: 494-7.
  10. Hall WA: The safety and efficacy of stereotactic biopsy for intracranial lesions. Cancer. 1998; 82: 174955.
  11. Hisatugo MK, Stavale JN, Bido JO, Ferraz FP. Image guided stereotactic approach of central nervous system lesions: accuracy, morbidity, mortality. Arq Neuropsiquiatr. 1999; 57: 615-20.
  12. Rajshekhar V, Chandy MJ. Computerized tomographyguided stereotactic surgery for brainstem masses: a risk-benefit analysis in 71 patients. J Neurosurg. 1995; 82: 976-81.
  13. Brainard JA, Prayson RA, Barnett GH. Frozen section evaluation of stereotactic brain biopsies: Diagnostic yield at the stereotactic target position in 188 cases. Arch Pathol Lab Med. 1997; 121: 481-4.
  14. Firlik KS, Martinez AJ, Lunsford LD. Use of cytological preparations for the intraoperative diagnosis of stereotactically obtained brain biopsies: a 19-year experience and survey of neuropathologists. J Neurosurg. 1999; 91: 454-8.
  15. Reyes MG, Homsi MF, McDonald LW, Glick RP. Imprints, smears, and frozen sections of brain tumors. Neurosurgery. 1991; 29: 575-9.
  16. Cappabianca P, Spaziante R, Caputi F et al. Accuracy of the analysis of multiple small fragments of glial tumors obtained by stereotactic biopsy. Acta Cytol. 1991; 35: 505-11.
  17. Feiden W, Steude U, Bise K, Gundisch O. Accuracy of stereotactic brain tumor biopsy: comparison of the histologic findings in biopsy cylinders and resected tumor tissue. Neurosurg Rev. 1991; 14: 51-6.
  18. Jackson RJ, Fuller GN, Abi-Said D et al. Limitations of stereotactic biopsy in the initial management of gliomas. Neuro-oncol. 2001; 3: 193-200. 19. Quick-Weller J, Lescher S, Kashefiolasl S, Weise LM, Seifert V, Marquardt G. Benefit of Stereotactic Procedures in a Series of 43 Children. J Child Neurol. 2016; 31: 907-12.
  19. Eibach S, Weise L, Setzer M, Seifert V, Senft C. Intraoperative bleeding in stereotactic biopsies and its implication on postoperative management: can we predict CT findings? Stereotact Funct Neurosurg. 2014; 92: 80-5.
  20. Kulkarni AV, Guha A, Lozano A, Bernstein M. Incidence of silent hemorrhage and delayed deterioration after stereotactic brain biopsy. J Neurosurg. 1998; 89:31-5.
  21. Scerrati M, Rossi GF. The reliability of stereotactic biopsy. Acta Neurochir Suppl. 1984; 33:201-5.
  22. Apuzzo ML, Chandrasoma PT, Cohen D, Zee CS, Zelman V. Computed imaging stereotaxy: Experience and perspective related to 500 procedures applied to brain masses. Neurosurgery. 1987; 20: 930-7.
  23. Bernstein M, Parrent AG. Complications of CT-guided stereotactic biopsy of intra-axial brain lesions. J Neurosurg. 1994; 81: 165-8. 25. Mundinger F. CT stereotactic biopsy for optimizing the therapy of intracranial processes. Acta Neurochir. Suppl. 1985; 35:70-74.